Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases with age as the greatest risk factor. As the general population experiences extended life span, preparation for the prevention and treatment of these and other age-associated neurological d...
Main Authors: | Amy H. Moore, Matthew J. Bigbee, Grace E. Boynton, Colin M. Wakeham, Hilary M. Rosenheim, Christopher J. Staral, James L. Morrissey, Amanda K. Hund |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/6/1812/ |
Similar Items
-
Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
by: Madiha Rasheed, et al.
Published: (2021-05-01) -
Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
by: Danail Minchev, et al.
Published: (2022-11-01) -
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
by: Paulina Troncoso-Escudero, et al.
Published: (2018-10-01) -
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
by: Arash Heidari, et al.
Published: (2022-06-01) -
Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification
by: Alexander Grotemeyer, et al.
Published: (2022-05-01)